Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 71,100 | 64,300 | 38,100 | 17,200 | 177,600 |
| Depreciation Amortization | 90,300 | 66,600 | 44,100 | 21,900 | 96,600 |
| Income taxes - deferred | 9,600 | 5,600 | 500 | -2,500 | 32,100 |
| Accounts receivable | 30,600 | -6,000 | 20,100 | 2,700 | -9,100 |
| Accounts payable and accrued liabilities | -28,300 | -17,100 | -20,700 | -12,000 | -1,300 |
| Other Working Capital | -19,000 | -49,100 | -37,400 | -41,900 | -125,400 |
| Other Operating Activity | -12,000 | 15,600 | -1,200 | 10,900 | -62,900 |
| Operating Cash Flow | $142,300 | $79,900 | $43,500 | $-3,700 | $107,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -63,900 | -48,200 | -32,700 | -17,000 | -76,500 |
| Net Acquisitions | N/A | -9,000 | -9,800 | -9,000 | -1,000 |
| Purchase Of Investment | -1,000 | -500 | -500 | -500 | -2,500 |
| Purchase Sale Intangibles | -9,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -6,100 | 2,800 | 2,800 | 1,000 | 177,600 |
| Investing Cash Flow | $-71,000 | $-54,900 | $-40,200 | $-25,500 | $97,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 900 | 500 | 300 | -102,900 |
| Common Stock Issued | 10,100 | 9,900 | 8,000 | 5,700 | 7,500 |
| Common Stock Repurchased | -52,300 | -48,800 | -29,000 | -16,600 | -63,100 |
| Financing Cash Flow | $-42,200 | $-38,000 | $-20,500 | $-10,600 | $-158,500 |
| Exchange Rate Effect | -2,300 | -2,200 | -2,000 | -1,400 | -1,900 |
| Beginning Cash Position | 56,800 | 56,800 | 56,800 | 56,800 | 12,000 |
| End Cash Position | 83,600 | 41,600 | 37,600 | 15,600 | 56,800 |
| Net Cash Flow | $26,800 | $-15,200 | $-19,200 | $-41,200 | $44,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 142,300 | 79,900 | 43,500 | -3,700 | 107,600 |
| Capital Expenditure | -63,900 | -48,200 | -32,700 | -17,000 | -76,500 |
| Free Cash Flow | 78,400 | 31,700 | 10,800 | -20,700 | 31,100 |